A PROSPECTIVE OBSERVATIONAL EXPLORATION OF MATERNAL AWARENESS OF NEONATAL JAUNDICE AND RISK ASSESSMENT
Keywords:
neonatal jaundice, maternal awareness, risk assessment, observational study, prospective study, bilirubinAbstract
Jaundice is the condition which is characterised by yellowish or greenish pigmentation of the skin and whites of the eyes due to high bilirubin levels. This condition is most commonly found in new-born and infants; however, it affects adults as well. Neonatal hyper bilirubinemia is the most common clinical condition in the newborn evaluation during the first week of postnatal life. Approximately 60% of term and 80% of preterm babies develop jaundice in the first week of life, and about 10% of breastfed babies are still jaundiced at 1 month of age. Jaundice is caused due to the accumulation of bilirubin (a yellow pigment) in the skin. When blood cells complete their life cycle, they are broken down in the body. Phototherapy and exchange transfusion are the mainstay of treatment for patients with unconjugated hyper bilirubinemia. Newborns with severe hyper bilirubinemia are at risk for bilirubin-induced neurologic dysfunction (BIND). The best prevention of infant jaundice is adequate feeding. Breast-fed infants should have eight to 12 feedings a day for the first several days of life. The primary goals of the current study are to evaluate the risk factors and maternal knowledge of neonatal jaundice and objective includes to educate mothers regarding neonatal jaundice and to increase the awareness about the neonatal jaundice. This survey highlights the mother's level of awareness of newborn jaundice. While mothers were aware of neonatal jaundice, their understanding of potential complications and treatment options was limited. Promoting awareness of neonatal jaundice among mothers is crucial for early detection and treatment, and during our study, the present study endeavoured to enhance mothers understanding of this condition.
References
Abbey, P., Kandasamy, D., Naranje, P. (2019): Neonatal jaundice. – The Indian Journal of Pediatrics 86(9): 830-841.
Amegan-Aho, K.H., Segbefia, C.I., Glover, N.D.O., Ansa, G.A., Afaa, T.J. (2019): Neonatal Jaundice: awareness, perception and preventive practices in expectant mothers. – Ghana Medical Journal 53(4): 267-272.
Benchimol, E.I., Walsh, C.M., Ling, S.C. (2009): Early diagnosis of neonatal cholestatic jaundice: test at 2 weeks. – Canadian Family Physician 55(12): 1184-1192.
Bhutani, V.K., Johnson, L.H., Jeffrey Maisels, M., Newman, T.B., Phibbs, C., Stark, A.R., Yeargin-Allsopp, M. (2004): Kernicterus: epidemiological strategies for its prevention through systems-based approaches. – Journal of Perinatology 24(10): 650-662.
Bizuneh, A.D., Alemnew, B., Getie, A., Wondmieneh, A., Gedefaw, G. (2020): Determinants of neonatal jaundice among neonates admitted to five referral hospitals in Amhara region, Northern Ethiopia: an unmatched case-control study. – BMJ Paediatrics Open 4(1): 9p.
Boskabadi, H., Rakhshanizadeh, F., Zakerihamidi, M. (2020): Evaluation of maternal risk factors in neonatal hyperbilirubinemia. – Archives of Iranian Medicine 23(2): 128-140.
Fawaz, R., Baumann, U., Ekong, U., Fischler, B., Hadzic, N., Mack, C.L., McLin, V.A., Molleston, J.P., Neimark, E., Ng, V.L., Karpen, S.J. (2017): Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. – Journal of Pediatric Gastroenterology and Nutrition 64(1): 154-168.
Feldman, A.G., Alonso, E.M., Whitington, P.F. (2017): Neonatal hemochromatosis. – Diseases of the Liver and Biliary System in Children 9p.
Gartner, L.M., Auerbach, K.G. (1987): Breast milk and breastfeeding jaundice. – Advances in Pediatrics 34(1): 249-274.
Goodman, O.O., Kehinde, O.A., Odugbemi, B.A., Femi-Adebayo, T.T., Odusanya, O.O. (2015): Neonatal jaundice: knowledge, attitude and practices of mothers in Mosan-Okunola community, Lagos, Nigeria. – Nigerian Postgraduate Medical Journal 22(3): 158-163.
Gottstein, R., Cooke, R.W.I. (2003): Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. – Archives of Disease in Childhood-Fetal and Neonatal Edition 88(1): F6-F10.
Hankø, E., Hansen, T.W.R., Almaas, R., Lindstad, J., Rootwelt, T. (2005): Bilirubin induces apoptosis and necrosis in human NT2-N neurons. – Pediatric Research 57(2): 179-184.
Hulzebos, C.V., Dijk, P.H., van Imhoff, D.E., Bos, A.F., Lopriore, E., Offringa, M., Ruiter, S.A., van Braeckel, K.N., Krabbe, P.F., Quik, E.H., van Toledo-Eppinga, L. (2014): The bilirubin albumin ratio in the management of hyperbilirubinemia in preterm infants to improve neurodevelopmental outcome: a randomized controlled trial–BARTrial. – PloS One 9(6): 16p.
Itoh, S., Okada, H., Kuboi, T., Kusaka, T. (2017): Phototherapy for neonatal hyperbilirubinemia. – Pediatrics International 59(9): 959-966.
Jackson, J.C. (1997): Adverse events associated with exchange transfusion in healthy and ill newborns. – Pediatrics 99(5): e7-e7.
Kaplan, M., Hammerman, C. (1998): Severe neonatal hyperbilirubinemia: a potential complication of glucose-6-phosphate dehydrogenase deficiency. – Clinics in Perinatology 25(3): 575-590.
Karadag, N., Zenciroglu, A., Eminoglu, F.T., Dilli, D., Karagol, B.S., Kundak, A., Dursun, A., Hakan, N., Okumus, N. (2013): Literature review and outcome of classic galactosemia diagnosed in the neonatal period. – Clinical Laboratory 59(9-10): 1139-1146.
Maisels, M.J., McDonagh, A.F. (2008): Phototherapy for neonatal jaundice. – New England Journal of Medicine 358(9): 920-928.
Morotti, R.A., Jain, D. (2013): Pediatric cholestatic disorders: approach to pathologic diagnosis. – Surgical Pathology Clinics 6(2): 205-225.
Murekatete, C., Muteteli, C., Nsengiyumva, R., Chironda, G. (2020): Neonatal jaundice risk factors at a district hospital in Rwanda. – Rwanda Journal of Medicine and Health Sciences 3(2): 204-213.
Myle, A.K., Al-Khattabi, G.H. (2021): Hemolytic disease of the newborn: a review of current trends and prospects. – Pediatric Health, Medicine and Therapeutics 8p.
Plosa, E.J., Esbenshade, J.C., Fuller, M.P., Weitkamp, J.H. (2012): Cytomegalovirus infection. – Pediatrics in Review 33(4): 156-163.
Provisional Committee on Quality Improvement & Subcommittee on Hyperbilirubinemia (1994): Practice parameter: management of hyperbilirubinemia in the healthy term newborn. – Pediatrics 94(4): 558-565.
Rennie, J.M. (2005): Roberton's textbook of neonatology. – Churchill Livingstone 1360p.
Salih, F.M. (2001): Can sunlight replace phototherapy units in the treatment of neonatal jaundice? An in vitro study. – Photodermatology, Photoimmunology & Photomedicine 17(6): 272-277.
Schneider, A.P. (1986): Breast milk jaundice in the newborn: A real entity. – JAMA 255(23): 3270-3274.
Sedlak, T.W., Snyder, S.H. (2004): Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. – Pediatrics 113(6): 1776-1782.
Shahid, R., Graba, S. (2012): Outcome and cost analysis of implementing selective Coombs testing in the newborn nursery. – Journal of Perinatology 32(12): 966-969.
Steinborn, M., Seelos, K.C., Heuck, A., Von Voss, H., Reiser, M. (1999): MR findings in a patient with kernicterus. – European Radiology 9: 1913-1915.
Stockman, J.A., de Alarcon, P.A. (2001): Overview of the state of the art of Rh disease: history, current clinical management, and recent progress. – Journal of Pediatric Hematology/Oncology 23(6): 385-393.
The, N.S., Honein, M.A., Caton, A.R., Moore, C.A., Siega‐Riz, A.M., Druschel, C.M. (2007): Risk factors for isolated biliary atresia, national birth defects prevention study, 1997–2002. – American Journal of Medical Genetics Part A 143(19): 2274-2284.
Wagemann, S.C., Nannig, P.M. (2019): Severe hyperbilirubinemia in newborns, risk factors and neurological outcomes. – Rev. Chil. Pediatr. Santiago 90(3): 267-274.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 SAMYUKTHA METTA, SHIVA TEJA AASALA, ABHISHEK KUMAR SINGH, BANDI BHAVISHA; AMULYA KAPPALA, SHIVANAND KHOKLE
This work is licensed under a Creative Commons Attribution 4.0 International License.
